LONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of […]
https://www.belluscura.com/wp-content/uploads/2019/04/0314_637231154360543565.jpg6661000Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-30 08:03:392020-10-07 16:10:04Belluscura announces filing of a patent application covering novel portable extracorporeal oxygenation and carbon dioxide removal systems for the treatment of acute respiratory distress syndrome (ARDS)
Visit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or […]
https://www.belluscura.com/wp-content/uploads/2019/03/UK-Investors-Show-Clean.jpg536850Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-28 09:23:522020-10-07 16:17:04Belluscura to present at UK Investor Show this Saturday
To date, we have brought on more than 100 investors from 12 countries and we are very thankful for all the interest in, and support of the X-PLOR. Our goal is to help patients suffering from chronic lung diseases, such as COPD, to enjoy more active and fulfilling lifestyles. Please join us in helping millions […]
https://www.belluscura.com/wp-content/uploads/2019/03/support2.jpg255387Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-25 12:16:442020-10-07 16:19:12Over 100 investors are now supporting Belluscura through crowdfunding!
Belluscura will be demonstrating the X-PLOR at the UK Investor Show on March 30. Come see us at Booth 65 for a hands-on experience with the world’s first modular portable oxygen concentrator.
We are getting numerous inquiries about the X-PLO2R being presented at the UK Investor Show. Having received so much interest, we decided to extend our crowdfunding campaign until April 5. Come see us at the show March 30 and don’t miss out on this unique investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors […]
Belluscura will be presenting on March 30 at the UK Investor Show. Come experience in-person the X-PLO2R’s unique features and advantages, and meet Belluscura CEO Bob Rauker and CFO Tony Dyer.
https://www.belluscura.com/wp-content/uploads/2019/03/1.jpg480852Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-14 08:39:562020-10-13 13:50:07See X-PLOR at the UK Investor Show
After just two weeks of our @Crowdcube campaign, we are already at 48% of our funding target! We are excited to have brought on 73 investors from 9 countries. 16 days remaining in the campaign, so don’t miss out on this unique healthcare investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in […]
https://www.belluscura.com/wp-content/uploads/2020/10/shutterstock_443536393-scaled.jpg17072560Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2019-03-06 09:26:152020-10-13 13:52:06Crowdfunding campaign reaches 48% of target in just two weeks!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy
HME News features X-PLOR
/in Belluscura News /by BelluscuraBelluscura announces filing of a patent application covering novel portable extracorporeal oxygenation and carbon dioxide removal systems for the treatment of acute respiratory distress syndrome (ARDS)
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of […]
Belluscura to present at UK Investor Show this Saturday
/in Belluscura News /by BelluscuraVisit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or […]
Over 100 investors are now supporting Belluscura through crowdfunding!
/in Belluscura News /by BelluscuraTo date, we have brought on more than 100 investors from 12 countries and we are very thankful for all the interest in, and support of the X-PLOR. Our goal is to help patients suffering from chronic lung diseases, such as COPD, to enjoy more active and fulfilling lifestyles. Please join us in helping millions […]
Visit Belluscura at Booth 65
/in Belluscura News /by BelluscuraBelluscura will be demonstrating the X-PLOR at the UK Investor Show on March 30. Come see us at Booth 65 for a hands-on experience with the world’s first modular portable oxygen concentrator.
Belluscura extends crowdfunding campaign
/in Belluscura News /by BelluscuraWe are getting numerous inquiries about the X-PLO2R being presented at the UK Investor Show. Having received so much interest, we decided to extend our crowdfunding campaign until April 5. Come see us at the show March 30 and don’t miss out on this unique investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors […]
See X-PLOR at the UK Investor Show
/in Belluscura News /by BelluscuraBelluscura will be presenting on March 30 at the UK Investor Show. Come experience in-person the X-PLO2R’s unique features and advantages, and meet Belluscura CEO Bob Rauker and CFO Tony Dyer.
Crowdfunding campaign reaches 48% of target in just two weeks!
/in Belluscura News /by BelluscuraAfter just two weeks of our @Crowdcube campaign, we are already at 48% of our funding target! We are excited to have brought on 73 investors from 9 countries. 16 days remaining in the campaign, so don’t miss out on this unique healthcare investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in […]